Patient Resources

06 Dec

New Therapy Helps Patients With Tough-to-Treat Bladder Cancers

Ernie Mundell HealthDay Reporter
December 6, 2024
Full Page

There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report.

An experimental new drug with the unwieldy name of cretostimogene grenadenorepvec spurred complete remission of the cancer in three-quarters of pati...

Cancer: Misc.Cancer: Bladder

18 Sep

Post-Op Keytruda Boosts Bladder Cancer Outcomes

HealthDay Reporter
September 18, 2024
Full Page

When given after organ-removal surgery, Keytruda brings patients battling advanced bladder cancers more time cancer-free, a new trial finds.

Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby...

Cancer: Bladder

29 Apr

King Charles Returns to Duties After Cancer Treatment

Ernie Mundell HealthDay Reporter
April 29, 2024
Full Page

Britain's King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced Friday.

"His Majesty The King will shortly return to public-facing duties after a period of treatment and recuperation following his recent cancer...

Cancer: Misc.Cancer: Bladder

08 Apr

Urine Test Could Cut Need for Painful Bladder Cancer Procedure

Dennis Thompson HealthDay Reporter
April 8, 2024
Full Page

A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report.

People who've gotten surgery for high-risk bladder cancer require a cystoscopy -- a procedure in which a flexible ...

Urine Problems Cancer: Bladder

11 Mar

Drug Combo Marks Advance Against Bladder Cancer

Ernie Mundell HealthDay Reporter
March 11, 2024
Full Page

A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.

Patients who took a combo of meds called EV+P -- enfortumab vedotin and pembrolizumab (Keytruda) -- had an average 31.5 months surviva...

Cancer: Bladder

10 Oct

Treatment Strategy Helps People With Advanced Bladder Cancer Retain the Organ

Alan Mozes HealthDay Reporter
October 10, 2023
Full Page

"Listen, I'm not a Pollyanna,"New Yorker David Cabelis makes clear. "I'm a cab driver."

"But I was diagnosed with this cancer,"the 72-year old said. "Bladder cancer, that's what I had, and then I had this treatment, and it was the most amazing experience. And thank God, ...

Cancer: Bladder

21 Jun

Could Loss of the Y Chromosome Help Speed Cancers in Men?

Dennis Thompson HealthDay Reporter
June 21, 2023
Full Page

It's common knowledge that loss is a part of male aging -- loss of hair, loss of muscle tone, loss of vision or hearing.

But men growing older also start losing the very thing that makes them biological males, their Y chromosome, and that can leave them more vulnerable t...

Cancer: Bladder DNA Genetics Men's Problems: Misc.

07 Jun

Patients With Bladder Cancer May Avoid Removal of Extra Lymph Nodes, Study Finds

Amy Norton HealthDay Reporter
June 7, 2023
Full Page

For years, doctors have thought that a more extensive surgery that removes a wider swath of lymph nodes was the best option for certain patients with bladder cancer. Now, a new clinical trial is upending that belief.

Researchers found that the strategy -- known as exten...

Surgery: Misc.Cancer: Bladder Clinical Trials

19 Dec

FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer

Cara Murez HealthDay Reporter
December 19, 2022
Full Page

Patients with a high-risk bladder cancer now have a new option to treat it.

The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what's called high-risk non-muscle-invasive bladder can...

Cancer: Bladder Gene Therapy Food &, Drug Administration

27 Oct

U.S. Cancer Death Rates Continue to Decline

Ernie Mundell HealthDay Reporter
October 27, 2022
Full Page

The latest statistics from the U.S. National Cancer Institute (NCI) show a continuing decline in the number of Americans who die from cancer, although there's been little change in the number of new cancer cases.

"From 2015 to 2019, overall cancer death rates decreased b...

Cancer: Bladder Cancer: Breast Cancer: Colon Cancer: Lung Cancer: Pancreatic Cancer: Prostate Cancer: Uterine

04 Oct

Football Great Terry Bradshaw Describes Battle Against Two Kinds of Cancer

HealthDay Reporter
By Cara Murez and Robin Foster HealthDay Reporters
October 4, 2022
Full Page

Football Hall of Famer Terry Bradshaw revealed Sunday that he has been treated for two different types of cancer in the past year.

Bradshaw

Cancer: Bladder Cancer: Skin

16 May

Immunotherapy Drug Can Lower Recurrence When Bladder Cancer Spreads

Steven Reinberg HealthDay Reporter
May 16, 2022
Full Page

Immunotherapy with nivolumab (Opdivo) after surgery for metastatic bladder cancer significantly reduces the odds for the tumor's return, a new clinical trial finds.

Among 700 patients with

Cancer: Bladder Clinical Trials

21 Mar

Missed Cancer Screenings During Pandemic Could Raise Death Rate for Years

HealthDay Reporter
March 21, 2022
Full Page

The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021.

The study, of more than 700 cancer facilities nationwide, found that i...

Colonoscopy Cancer: Kidney Liver Cancer: Thyroid Mammography Cancer: Bladder Cancer: Brain

06 Dec

More Evidence That Pandemic Delayed Cancer Diagnoses

HealthDay Reporter
Robert Preidt
December 6, 2021
Full Page

New research offers fresh proof that the COVID-19 pandemic delayed cancer diagnoses in the United States, increasing patients' risk for poor outcomes.

For the study, researchers analyzed data from more than 9 million patients at over 1,200 Veterans Affairs (VA) medical f...

CAT Scans Cancer: Bladder Cancer: Colon Cancer: Lung Cancer: Prostate Colonoscopy Screening

13 Oct

Cancer Care Costs U.S. $156 Billion Per Year; Drugs a Major Factor

HealthDay Reporter
Robert Preidt
October 13, 2021
Full Page

Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.

Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State C...

Cancer: Bladder Cancer: Breast Cancer: Colon Cancer: Esophageal Cancer: Kidney Liver Cancer: Lung Cancer: Lymphoma Cancer: Pancreatic

Show All Health News Results